Title: John T Ransom: Innovator in Pharmaceutical Sciences
Introduction
John T Ransom is a notable inventor in the field of pharmaceutical sciences, particularly recognized for his work on modulators of CRAC channels. He is based in the United States and has made significant contributions to the understanding of calcium release-activated calcium (CRAC) channels.
Latest Patents
John T Ransom holds a patent titled "Modulators Of Ca2+ Release-Activated Ca2+ (Crac) Channels And Pharmaceutical Uses Thereof." This patent describes compounds that modulate the activity of CRAC channels, methods of making such compounds, pharmaceutical compositions, and medicaments containing such compounds. Additionally, it outlines methods for using these compounds in the treatment of conditions, diseases, or disorders associated with CRAC channel activity. Despite having 0 patents, his research is impactful in the pharmaceutical industry.
Career Highlights
John T Ransom is currently employed at Vivreon Biosciences, LLC, where he continues to advance his research in pharmaceutical applications. His work focuses on innovative solutions that address critical health issues related to CRAC channel activity.
Collaborations
Throughout his career, John has collaborated with esteemed colleagues, including Milton L Greenberg and Clayton A White. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical solutions.
Conclusion
John T Ransom is a dedicated inventor whose work in modulating CRAC channels has the potential to lead to significant advancements in medical treatments. His contributions to the field of pharmaceutical sciences are noteworthy and continue to inspire future innovations.